David Lapidus is the founder of LapidusData LLC, a consulting firm specializing in market validation services for companies developing orphan drugs. Mr. Lapidus has extensive experience in interpreting epidemiology and market research to create financial models for therapies where underlying population dynamics are complex or poorly characterized. Mr. Lapidus’s financial models have been used to support successful M&A activity in the orphan drug field. In addition, established orphan drug companies with marketed products use LapidusData market forecasting systems for sales, marketing, and budgetary planning. Before founding LapidusData LLC, Mr. Lapidus began his pharma career at Decision Resources, a pharmaceutical consulting firm. After contributing several innovations to this company’s forecasting process, he moved to Genzyme, where he built a market forecasting system for the enzyme replacement therapy business unit. Mr. Lapidus holds a BA in Social Studies from Harvard University.